FindTrial
Sign In

To study prevalence of Disorders of Breathing during sleep, like Sleep Apnea, in patients who have completed their treatment for any Oral Cancer.

A Pilot Cross-sectional Study of the Prevalence of Sleep Disordered Breadthing and Sleep Apnnea in Treated Locoregionally Controlled Head and Neck Cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2010/091/000555
Enrollment
100
Registered
2010-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Sleep disordedred Breadthing and Obstructive Sleep Apnea Hypopnea Syndrome

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Centre Intramural Fund
Lead Sponsor
No sponsor for the study
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Locoregionally controlled oral and oropharyngeal tumours who have completed treatment atleast 6 months prior to study in the form of either surgery or radiotherapy or surgery and radiotherapyor chemoradiation with the following surgical types: 1.mandibular resection either middle third ,hemi or extended hemimandibulectomy 2.more than hemiglossectomy 3.total glossectomy 4.oropharyngeal resection not involving larynx 5.major resection causing significant alteration of upper airway anatomy with major reconstruction.

Exclusion criteria

Exclusion criteria: 1.Laryngeal tumours or resections or patients who have a tracheostomy 2.Haemodynamically unstable patients 3.Patients already diagnosed pre-treatment as SDB/OSAHS.

Design outcomes

Primary

MeasureTime frame
To detect incidence of SBD(sleep disordered breathing)and OSAHS(obstructive sleep apnea hypopnea syndrome)in treated locoregionally controlled Head and Neck cancer patients. Timepoint: NA—

Secondary

MeasureTime frame
To study quality of life and mental health of these patients and ascertain any association with SDB and OSAHS. Timepoint: NA—

Countries

India

Contacts

Public ContactDr Sandeep Tandon
sptandon@gmail.com24177000 extn4637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026